Rating: HOLD
HOLD (5-tier) · cyclical compounder · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $158 |
| Triangulated Fair Value | $154 (-3% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $167 (+6% vs spot · 12m PWEV) |
| Forward P/E | 18.9x |
| Market Cap | $85B |
| 52-Week Range | $139–$176 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | cyclical compounder · medium |
| Triangulated fair value | $154 (-3% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $167 (+6% vs spot · 12m PWEV) |
| Next catalyst | 2026-07-17 — Quarterly earnings |
| Primary thesis-break | Organic revenue growth (YoY, reported) < 0.015 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +6% vs spot
- Monte Carlo median implies -5% vs spot
- DCF fair value implies -15% vs spot
- Bear case (Structural — Portfolio / End-Market Disruption) downside is -52% vs spot
- Net: reward/risk of 0.1× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At 161.91 the shares trade near 19x forward earnings, a mid-cycle multiple that assumes 3M restores organic growth toward 5% and holds operating margin around 21.6% while legacy PFAS and earplug liabilities stay within reserve. The engine's probability-weighted target of 167.6 sits only 3.5% above spot, so the rating is HOLD. The engine differs from a straight quality-compounder read in two ways: it weights the structural-impairment path at 20% with a 73.74 target below the 52-week low of 138.62, and its Monte Carlo attributes 61% of variance to the P/E multiple, not earnings. That reflects genuine re-rating risk, not a smooth compounding base. The DCF anchor of 135.45 sits well below spot, so the market is paying for a multiple the cash flows do not yet support. The single most damaging risk is litigation: a settlement cash outflow above reserve would compress the -8.83B net-debt position, halt buybacks, and pull the outcome toward the structural path. Balance of evidence keeps the name range-bound, not cheap.
The dashboard below is the whole argument on one page: spot ($158) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear mechanism is the mid-cycle-to-recession slide. 3M is short-cycle: roughly half of revenue turns on distributor restocking and industrial PMI. A synchronised PMI contraction cuts volumes 2-3%, and because a large fixed-cost base sits under the plants, operating margin drops from 21.6% toward 19.0% on negative operating leverage. Pricing, which carried recent results, fades as customers de-stock. On the PMI-Recession path EPS falls to roughly 6.93 and the multiple compresses to 18x, producing a 125 target, 23% below spot. This is not a tail: the industry house view places the recession/inventory-reset state at 37% probability. The DCF at 135 already implies the market is over-paying for mid-cycle earnings that a single soft-demand year could remove.
Key Debate
P/E Multiple explains 61% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.38 vs analyst floor +0.15 → delta +0.23 (n=21 mgmt / 13 Q&A; 17th pctile across the S&P book, z -1.0).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.38 | +0.15 | +0.23 |
| 2025Q4 | +0.40 | +0.18 | +0.21 |
| 2025Q3 | +0.48 | +0.37 | +0.12 |
| 2025Q2 | +0.49 | +0.19 | +0.31 |
News (last 365d, 1000 articles): avg ticker sentiment +0.08 (bullish 7% / bearish 6%)
Scenario Analysis
The tree runs from a structural 'Structural — Portfolio / End-Market Disruption' downside ($75) to a 'Bull — Re-Rate' bull case ($290); the probability-weighted blend (PWEV $167) is +6% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Portfolio / End-Market Disruption | 20% | $75 | -52% |
| Industrial-PMI Recession | 17% | $125 | -21% |
| Base — Organic Growth + Margin | 35% | $173 | +10% |
| Growth — Productivity / Reshoring / Automation | 20% | $234 | +48% |
| Bull — Re-Rate | 8% | $290 | +83% |
| Probability-Weighted (PWEV) | — | $167 | +6% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Portfolio / End-Market Disruption (20%, $75). Structural impairment — portfolio / end-market disruption: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 73.74; probability: 0.2.
- Industrial-PMI Recession (17%, $125). Cyclical downturn — short-cycle industrial demand (PMI) + pricing + portfolio/automation mix weakens for 1–2 years before normalising. Drivers — implied_target: 125.23; probability: 0.17.
- Base — Organic Growth + Margin (35%, $173). Mid-cycle — normalised short-cycle industrial demand (PMI) + pricing + portfolio/automation mix; disciplined capital allocation; steady returns. Drivers — implied_target: 173.93; probability: 0.35.
- Growth — Productivity / Reshoring / Automation (20%, $234). Upside — productivity + reshoring + automation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 234.81; probability: 0.2.
- Bull — Re-Rate (8%, $290). Upside tail — sustained tight conditions or a structural re-rate on productivity + reshoring + automation. Drivers — implied_target: 296.55; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $150 | -5% |
| Peer P/E re-rate | multiple | $193 | +22% |
| Peer EV/Revenue re-rate | multiple | $184 | +16% |
| Scenario PWEV | multiple | $167 | +6% |
| DCF (5-year + terminal) | cash flow + terminal × | $135 | -15% |
| Triangulated (weighted) | — | $154 | -3% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $150 and 45% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (61% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 17x terminal FCF multiple → $135. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 23.015x) implies $193. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 35% of the median — moderate (healthy method disagreement — read the blend with care).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Diversified Industrial Machinery | $25.0B | 100% | 5% | 22% | $5.4B | 20x | 3% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | short-cycle industrial demand (PMI) + pricing + portfolio/automation mix |
| net_debt_or_cash_b | -8.83 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.0179 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | portfolio / end-market disruption |
| upside | productivity + reshoring + automation |
Industry Context — Ind Machinery
This name sits in the Ind Machinery as a diversified_industrials. short-cycle industrial demand (PMI) + pricing + portfolio/automation mix Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: CAT (heavy_machinery) · DE (heavy_machinery) · HON (diversified_industrials) · PH (diversified_industrials) · CMI (heavy_machinery) · MMM (diversified_industrials) · ITW (diversified_industrials) · GWW (diversified_industrials) · PCAR (heavy_machinery) · WAB (heavy_machinery) · IR (diversified_industrials) · DOV (diversified_industrials) · OTIS (diversified_industrials) · HUBB (diversified_industrials) · XYL (diversified_industrials) · SNA (diversified_industrials) · FTV (diversified_industrials) · NDSN (diversified_industrials) · IEX (diversified_industrials) · SWK (diversified_industrials) · PNR (diversified_industrials)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Industrial-PMI Recession / Inventory Reset | 37% | 37% | |
| Mid-Cycle — Volumes + Pricing | 35% | 35% | |
| Upcycle — Capex / Reshoring / Infra | 28% | 28% |
Mapping note: name-level 'Structural — Portfolio / End-Market Disruption' (20%) + 'Industrial-PMI Recession' (17%) map to cluster Industrial-PMI Recession / Inventory Reset (37%); name-level 'Growth — Productivity / Reshoring / Automation' (20%) + 'Bull — Re-Rate' (8%) map to cluster Upcycle — Capex / Reshoring / Infra (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Industrial-PMI Recession / Inventory Reset () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The ind_machinery cycle is the shared macro driver. Driver — industrial capex + PMI + construction/ag/heavy-truck demand + reshoring Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $26B | $6B | $1B | $1B | $5B | $4B |
| FY+2 | $28B | $6B | $1B | $1B | $5B | $4B |
| FY+3 | $29B | $7B | $1B | $1B | $5B | $4B |
| FY+4 | $30B | $7B | $1B | $1B | $5B | $4B |
| FY+5 | $31B | $7B | $1B | $1B | $6B | $4B |
| Terminal | — | — | — | — | $6B × 17x | $61B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $20B + PV(terminal) $61B = EV $81B; + net cash → equity $72B ÷ diluted shares 0.54B = $135/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $126/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 21% vs WACC 9% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| HON | 4.473x | 21.64x | 5% | 21% |
| JCI | 3.994x | 25.06x | 5% | 14% |
| CSX | 7.34x | 24.39x | 4% | 36% |
| ADP | 4.118x | 18.08x | 6% | 30% |
| Median | 4.2955000000000005x | 23.015x | — | — |
Peer-median fwd P/E → $193; EV/Rev → $184.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $135 | 41% | $55 |
| Scenario PWEV | $167 | 29% | $49 |
| Monte Carlo median | $150 | 18% | $26 |
| Peer P/E | $193 | 12% | $23 |
| Triangulated | — | 100% | $154 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 11.9x | 14.4x | 17.0x | 19.5x | 22.1x |
|---|---|---|---|---|---|
| 7% | $110 | $129 | $148 | $166 | $186 |
| 8% | $105 | $123 | $141 | $159 | $177 |
| 9% | $100 | $117 | $135 | $152 | $169 |
| 10% | $96 | $112 | $129 | $145 | $161 |
| 11% | $92 | $107 | $123 | $138 | $154 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $99 | $107 | $116 | $125 | $133 |
| -1.5pp | $106 | $116 | $125 | $134 | $144 |
| +0.0pp | $115 | $125 | $135 | $145 | $155 |
| +1.5pp | $124 | $134 | $145 | $155 | $166 |
| +3.0pp | $133 | $144 | $156 | $167 | $178 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $116 | $156 | $40 |
| Op margin ±3pp | $115 | $155 | $40 |
| Terminal × ±15% | $118 | $152 | $34 |
| WACC ±1pp | $129 | $141 | $12 |
| Capex intensity ±15% | $130 | $139 | $9 |
Company lever — SoP/share vs Diversified Industrial Machinery multiple (AI re-rating) (base 20x)
| Multiple | 14.0x | 17.0x | 20.0x | 23.0x | 26.0x |
|---|---|---|---|---|---|
| SoP/share | $639 | $779 | $920 | $1,060 | $1,201 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $171 (+8% vs spot · street) |
| House target | $168 (-2.0% vs street) |
| Sell-side coverage | 18 analysts (SB 0 / B 8 / H 7 / S 0 / SS 3; net score 0.06) |
| Consensus FY EPS | $9.48; house below (-11.6%) |
| Consensus FY revenue | $26.0B; house in-line (+1.2%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $7.0B — modestly levered |
| Net debt / EBITDA | 1.12x |
| Interest coverage (EBIT / interest) | 6.9x |
| Current ratio | 1.71x |
| Cash & ST investments | $5.9B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.4B |
| Buybacks / dividends | $4.8B / $1.2B |
| Total shareholder yield | 7.1% |
| Payout as % of FCF | 428.9% |
| Reinvestment (capex / OCF) | 39.5% |
| SBC as % of FCF | 16.1% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 5.6% |
| FCF conversion (FCF / net income) | 42.8% |
| FCF yield | 1.6% |
| Capex intensity (capex / revenue) | 3.6% |
| FCF − SBC (diagnostic) | $1.2B |
| Capex split (maint / growth) | 70% / 30% — Capital-light diversified industrial (~3% of revenue capex); spend is dominated by plant maintenance, automation and PFAS remediation infrastructure, with a limited growth slug given the restructuring focus. |
Accounting quality: SBC 0.9% of revenue; cash conversion (OCF/NI) 71% — earnings not cash-backed.
Catalyst Calendar
- 2026-07-17 (~9d) — Quarterly earnings — est. EPS $2.26 (AV EARNINGS_CALENDAR)
- 2026-11-01 (~116d) — New-product vitality index / R&D-productivity update at investor day (authored)
- 2026-12-15 (~160d) — PFAS multi-district / state-AG settlement milestones (authored)
- 2027-02-15 (~222d) — FY2026 results with FY2027 organic-growth and margin guide (authored)
Forecast Track Record
- EPS surprise: beat 100.0% of the last 8 quarters; average surprise +7.2%.
Competitive Moat
Narrow moat. 3M's edge is a diffuse portfolio of formulation/materials IP and brand distribution, but it has under-invested in R&D productivity and carries open PFAS/earplug liabilities; if organic growth fails to reach ~5% and liabilities exceed reserves, the ~19x forward multiple is unjustified and the terminal multiple should compress toward the diversified-industrial group (~15-16x).
Moat sources:
- Broad materials-science/formulation IP and patent estate across abrasives, adhesives, films
- Brand and distribution incumbency in industrial and consumer channels
- Eroded innovation cadence - R&D productivity questioned after years of underperformance
- Contingent PFAS and Combat Arms earplug liabilities offset the intangible moat
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| PFAS 'forever chemicals' litigation and EPA/state cleanup liabilities | high (~70%) | high - reserve adequacy is the swing variable ~10-15% of FV | 12-24m |
| Combat Arms earplug settlement funding/execution | medium (~40%) | medium - overhang on FCF as instalments are paid ~4-6% of FV | 12-24m |
| Global product-stewardship / chemical bans on legacy product lines | medium (~35%) | low - phased exits with modest revenue at risk ~2-3% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Portfolio / End-Market Disruption | Secular disruption of legacy product lines plus persistent share loss to more innovative rivals resets the earnings base | Weak R&D vitality means lost share is not recovered; the portfolio structurally shrinks |
| Industrial-PMI Recession | Synchronised global industrial PMI contraction cuts short-cycle volumes 2-3% against a fixed cost base | High operating leverage on ~half of revenue turns a modest volume dip into an outsized margin hit |
| Base — Organic Growth + Margin | Organic growth restored toward ~5% with operating margin held near 21-22% and liabilities within reserves | PFAS/earplug payouts exceeding reserves would undercut the FCF the base case assumes |
| Growth — Productivity / Reshoring / Automation | Reshoring and factory-automation demand plus internal productivity lift volumes and margins together | The reshoring benefit is diffuse and slow; execution risk under a turnaround management team |
| Bull — Re-Rate | Liabilities resolved within reserves and innovation re-accelerates, prompting a multiple re-rating | A re-rating requires both clean legal resolution and proven organic growth - a demanding double |
What the Market Is Pricing In
At the current price, the market pays 16.7× forward EPS, vs the house DCF terminal 17.0×, and a peer median 23.015×. The house DCF sits 15% below spot, so the market is pricing in more than the house case — roughly 1.5pp of revenue CAGR.
Variant perception: the house view is in-line with consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 26.0 | 26.3 | High |
| EPS | 9.5 | 8.4 | Medium |
| Target price | 171.0 | 167.6 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| HON | 21.64× | 5% | 21% | direct | 100% |
| JCI | 25.06× | 5% | 14% | segment | 50% |
| CSX | 24.39× | 4% | 36% | segment | 50% |
| ADP | 18.08× | 6% | 30% | direct | 100% |
Quality-weighted forward P/E: 21.5× (simple median 23.015×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $139–$176, centre $156 (-1% vs spot); spot sits at the 52th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $154 (-3% vs spot · triangulated FV) |
| Downside to bear case (Structural — Portfolio / End-Market Disruption) | $75 (-52% vs spot · bear scenario) |
| Reward/risk ratio | 0.1× |
| Margin of safety (FV vs spot) | -3% |
| P(price > spot) — Monte Carlo | 45% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $290.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 9.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 17× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (40.0); Op margin ±3pp (40.0); Terminal × ±15% (34.0); WACC ±1pp (12.0); Capex intensity ±15% (9.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $25.0B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $26.3B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $9.4833 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.537B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $7.003B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 9.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 17× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 9%, terminal multiple 17×, FY+5 revenue $31B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic revenue growth (YoY, reported) < 0.015 (2 consecutive prints → ind_machinery). Base assumes ~5% organic growth. Two prints below 1.5% would place volumes near the PMI-recession path (-2%) rather than mid-cycle, undercutting the Base target.
- Non-GAAP operating margin < 0.2 (2 consecutive prints → ind_machinery). Base op margin is 21.6%. Sustained sub-20% margin signals pricing loss or cost inflation consistent with the PMI-Recession path (19.0%), pressuring EPS below the Base line.
- Free cash flow conversion (FCF / net income) < 0.85 (2 consecutive prints → ind_machinery). Capital discipline and high FCF conversion underpin the dividend and buyback. Conversion below 0.85 across two prints would signal working-capital strain or legacy-liability cash drag, weakening the capital-return thesis.
- Litigation / legacy-liability cash outflow (PFAS + earplug settlements) > 1.5 (single event → ind_machinery). A single-year settlement cash outflow above $1.5B beyond current reserves would compress net cash, constrain buybacks, and validate the Structural (portfolio/end-market disruption) path.
- Trailing capex ($B annual) > 1.3 (2 consecutive prints → ind_machinery). Schedule assumes capex normalising near $0.92-1.05B. Two years above $1.30B without a matching margin step signals value-dilutive reinvestment, pressuring incremental ROIC below the DCF assumption.
Fact / Inference / Speculation
- FACT: Spot $158; 52-week range $139–$176; engine rating HOLD; base-case target $168 (+6%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $154 (-3% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $154 (-3% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.